NanoViricides
NNVC
31 hedge funds and large institutions have $2.3M invested in NanoViricides in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
310% more call options, than puts
Call options by funds: $516K | Put options by funds: $126K
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
24% more funds holding
Funds holding: 25 → 31 (+6)
10% more capital invested
Capital invested by funds: $2.09M → $2.3M (+$207K)
1.87% more ownership
Funds ownership: 9.65% → 11.52% (+1.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$92.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$78.2K |
| 3 |
Two Sigma Investments
New York
|
+$74.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.8K |
| 5 |
Morgan Stanley
New York
|
+$51.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$11.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$2.18K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$2K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$1.09K |
NNVC Hedge Fund Activity: Q3 2022 in Review
31 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2022, worth a combined $2.3M — up 9.9% from $2.09M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NNVC positions and 3 closed out — a net gain of 6 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $92.3K. The largest seller was UBS Group, cutting an estimated $11.4K.
- 31 institutional investors held NanoViricides (NNVC) as of Q3 2022, up from 25 in Q2 2022.
- Funds reported $2.3M of NanoViricides stock for Q3 2022, up 9.9% quarter-over-quarter.
- 9 funds opened new NanoViricides positions in Q3 2022 and 3 closed out, a net change of +6 holders.
- The largest NanoViricides buyer in Q3 2022 was Millennium Management, an estimated $92.3K added.
- The largest NanoViricides seller in Q3 2022 was UBS Group, an estimated $11.4K sold.
Based on aggregated 13F filings for Q3 2022.